New Podcast: Companion Diagnostics - Regulatory Improvements, Market Trends & Emerging Technologies

July 25, 2014 - PRLog -- We know that the diagnostic test to stratify patients and guide therapy are becoming a reality in the healthcare setting. The technology is maturing and the companion diagnostics market is getting tighter. Based on that, Genomic Health’s Richard A. White, Ph.D., answers these questions during an interview with Cambridge Healthtech Institute (CHI):

* Is there any room left for improvement in the companion diagnostics offering, and if there is a room for improvement, can you predict the future for us?

* What are the technologies and companion diagnostics moving to, in general?

LISTEN TO THIS PODCAST BY COPY/PASTING THIS URL INTO YOUR BROWSER:
http://www.nextgenerationdx.com/NextGeneration_Content.aspx?id=140280

Dr. White is presenting at the 5th Annual “Companion Diagnostics: Technology & Reimbursement” conference (part of the Next Generation Dx Summit) to be held on August 20-21, 2014 at the Capital Hilton Hotel in  Washington, DC. Dr. White will speak about the use of POC in oncology outpatient practices.   For more information, visit http://www.www.nextgenerationdx.com/companion-diagnostics.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.